Status:
COMPLETED
Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
DSM Nutritional Products, Inc.
Conditions:
Obesity
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
The body of evidence regarding the health benefits of green tea has grown considerably during the last decade and includes antioxidant properties, anti- cancer, anti-obesity and anti-diabetes effects....
Eligibility Criteria
Inclusion
- Age between 20 and 50 y
- BMI 25.0-29.9 kg/m2
- Normal fasting glucose \<6.1 mmol/L
- Blood pressure (systolic blood pressure 100-150 mmHg, diastolic blood pressure 60-90 mmHg)
- Weight stable in last 3 months (±2 kg)
Exclusion
- pregnant, lactating or (post)menopausal women
- regular smokers
- people with intensive fitness training eg athletes
- habitual consumption of green or black tea (more than 1 or 2 cups a day, respectively)
- not more than 300 mg/day caffeine consumption
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00867555
Start Date
October 1 2008
End Date
May 1 2009
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept Human Biology, Maastricht University
Maastricht, Netherlands, 6200 MD